Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)
Clinical trial NCT04706975 · COMPLETED
Trial details
- NCT number
- NCT04706975
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2022-05-18
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.